FRONTIER IP GROUP PLC
FIPP | IL
Overview
Corporate Details
- ISIN(s):
- GB00B63PS212
- LEI:
- 213800BRYUKQPJWKJ312
- Country:
- United Kingdom
- Address:
- 93 GEORGE STREET, EH2 3ES EDINBURGH
- Website:
- https://www.frontierip.co.uk/
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
Fusion Antibodies provides end-to-end antibody development services, from antigen design to cell line development, aiming to advance antibodies to the clinic while considering manufacturability and commercialization.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-04-02 17:47 |
Director's Dealing
Director/PDMR Shareholding
|
English | 23.4 KB | |
| 2025-03-26 08:00 |
Earnings Release
Unaudited Half Year Results
|
English | 184.0 KB | |
| 2025-03-18 08:00 |
Regulatory News Service
Pulsiv wins PSMA’s Global Energy Efficiency Award
|
English | 18.1 KB | |
| 2025-02-25 08:00 |
Environmental & Social Information
GraphEnergyTech collaboration & Innovate UK grant
|
English | 18.3 KB | |
| 2025-02-18 08:00 |
Regulatory News Service
Topps Tiles launches Alusid’s Mas floor tiles
|
English | 17.5 KB | |
| 2025-01-08 08:00 |
Regulatory News Service
Alusid signs international distribution agreement
|
English | 15.6 KB | |
| 2024-12-31 14:30 |
Declaration of Voting Results & Voting Rights Announcements
Total Voting Rights
|
English | 10.9 KB | |
| 2024-12-30 10:56 |
Major Shareholding Notification
Holding(s) in Company
|
English | 21.5 KB | |
| 2024-12-20 08:00 |
Director's Dealing
Grant of Options
|
English | 40.9 KB | |
| 2024-12-19 17:14 |
Post-Annual General Meeting Information
Result of AGM
|
English | 61.0 KB | |
| 2024-11-29 18:00 |
Declaration of Voting Results & Voting Rights Announcements
Total Voting Rights
|
English | 11.6 KB | |
| 2024-11-29 14:36 |
Major Shareholding Notification
Holding(s) in Company
|
English | 22.0 KB | |
| 2024-11-27 08:00 |
Report Publication Announcement
Posting of Circular & Annual Report, & AGM Notice
|
English | 13.4 KB | |
| 2024-11-26 08:00 |
Share Issue/Capital Change
Result of Retail Offer
|
English | 15.4 KB | |
| 2024-11-22 14:31 |
Share Issue/Capital Change
Result of Placing and Subscription
|
English | 35.1 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
Novo Nordisk | Denmark | NOVO | |
|
NRGene Technologies Ltd. | Israel | NRGN | |
|
NUFORMIX PLC | United Kingdom | NFX | |
|
Nykode Therapeutics ASA | Norway | NYKD | |
|
Oculis Holding AG | Switzerland | OCS | |
|
ONCODESIGN | France | ALONC | |
|
Oncodesign Precision Medicine S.A | France | ALOPM | |
|
Oncoinvent ASA | Norway | OCIN | |
|
Oncopeptides | Sweden | ONCO | |
|
Onxeo | France | ALONX |